ELSI is Our Next Battlefield

We have never been ELSI researchers – there is no need for a post-ELSI shift

This article criticizes recent suggestions that the current ELSI research field should accommodate a new direction towards a 'post-ELSI' agenda. Post-ELSI research seeks to avoid the modernist division of responsibility for technical and social issues said to characterize ELSI research. Collaboration and integration are consequently the key terms of post-ELSI strategies that are to distinguish ...

Cannabis: the next villain on the lung cancer battlefield?

L ung cancer epidemics arose and spread in western countries when the tobacco industry created the manufactured cigarette and realised that nicotine addiction was the most adaptable way to increase and secure long-term sales [1]. In spite of well-known toxicity of tobacco smoke [2] and the proven relationship of tobacco smoking with lung cancer incidence [3], the tobacco industry took advantage...

Exsanguination shock: the next frontier in prevention of battlefield mortality.

Heretofore, those wounded in combat who arrived at a deployed medical treatment facility with signs of life and subsequently died have been designated as having died of wounds, with the vast majority classified as dying due to “hemorrhage” from nondescript hemorrhagic shock.1–4 In the future, the development and use of new technology may offer the greatest potential for decreasing mortality amo...

This is dedicated to our former chairman Dr. Mahmoud Rohani

your problem is our problem